Abbvie To Buy Allergan For $60 Billion In Latest Pharma Megadeal
June 25, 2019 at 08:14 AM EDT
Abbvie will pay most of the price, represents a 45% premium over Allergan’s closing share price Monday of $129.57, in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|